Reviewing Cyanotech (CYAN) and Conversion Labs (CVLB)

Cyanotech (NASDAQ:CYAN) and Conversion Labs (OTCMKTS:CVLB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

Profitability

This table compares Cyanotech and Conversion Labs’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cyanotech -2.31% -4.18% -2.50%
Conversion Labs -11.82% -253.98% -138.05%

Institutional and Insider Ownership

16.7% of Cyanotech shares are owned by institutional investors. 24.5% of Cyanotech shares are owned by company insiders. Comparatively, 31.0% of Conversion Labs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Cyanotech has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500. Comparatively, Conversion Labs has a beta of -0.34, suggesting that its stock price is 134% less volatile than the S&P 500.

Earnings & Valuation

This table compares Cyanotech and Conversion Labs’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cyanotech $34.12 million 0.58 $1.02 million N/A N/A
Conversion Labs $5.05 million 1.85 -$1.20 million N/A N/A

Cyanotech has higher revenue and earnings than Conversion Labs.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Cyanotech and Conversion Labs, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cyanotech 0 0 0 0 N/A
Conversion Labs 0 0 0 0 N/A

Summary

Cyanotech beats Conversion Labs on 7 of the 9 factors compared between the two stocks.

About Cyanotech

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, as well as directly to consumers; and in bulk quantities to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.

About Conversion Labs

Conversion Labs, Inc., an Internet based direct response marketing company, manufactures and sells personal care and nutritional supplement products. Its products portfolio include Shapiro MD, a shampoo, conditioner, and leave-in foamer for men and women; and iNR Wellness, a daily nutritional supplement that contains yeast, oat, and mushroom beta glucans. The company sells its products worldwide through technology infrastructure and relationships with agencies, third party marketers, and online advertising platforms, as well as through its Websites inrwellness.com and shapiromd.com. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was incorporated in 1987 and is based in New York, New York.

Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply